Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2013, Article ID 134241, 4 pages
http://dx.doi.org/10.1155/2013/134241
Case Report

Successful Management of a Giant Pituitary Lactosomatotroph Adenoma Only with Cabergoline

1Department of Endocrinology and Metabolism Diseases, Faculty of Medicine, Baskent University, Turkey
2Department of Internal Medicine, Faculty of Medicine, Baskent University, Turkey

Received 13 March 2013; Accepted 20 April 2013

Academic Editors: M. A. Boyanov and T. Usui

Copyright © 2013 Emre Bozkirli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. V. Lloyd, K. Kovacs, W. F. Young Jr. et al., “Tumours of the pituitary,” in WHO Classification of Tumours-Tumours of Endocrine Organs, R. A. DeLellis, R. V. Lloyd, P. U. Heitz et al., Eds., pp. 11–12, IARC Press, Lyon, France, 2004. View at Google Scholar
  2. B. Schaller, “Gender-related differences in prolactinomas. A clinicopathological study,” Neuroendocrinology Letters, vol. 26, no. 2, pp. 152–159, 2005. View at Google Scholar · View at Scopus
  3. A. Colao, “Pituitary tumours: the prolactinoma,” Best Practice & Research Clinical Endocrinology & Metabolism, vol. 23, pp. 575–596, 2009. View at Google Scholar
  4. R. K. Shrivastava, M. S. Arginteanu, W. A. King, and K. D. Post, “Giant prolactinomas: clinical management and long-term follow up,” Journal of Neurosurgery, vol. 97, no. 2, pp. 299–306, 2002. View at Google Scholar · View at Scopus
  5. A. Goel, T. Nadkarni, D. Muzumdar, K. Desai, U. Phalke, and P. Sharma, “Giant pituitary tumors: a study based on surgical treatment of 118 cases,” Surgical Neurology, vol. 61, no. 5, pp. 436–445, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. C. I. Ferrari, R. Abs, J. S. Bevan et al., “Treatment of macroprolactinoma with cabergoline: a study of 85 patients,” Clinical Endocrinology, vol. 46, no. 4, pp. 409–413, 1997. View at Google Scholar · View at Scopus
  7. I. Shimon, C. Benbassat, and M. Hadani, “Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men,” European Journal of Endocrinology, vol. 156, no. 2, pp. 225–231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Del Dotto and U. Bonuccelli, “Clinical pharmacokinetics of cabergoline,” Clinical Pharmacokinetics, vol. 42, no. 7, pp. 633–645, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Webster, G. Piscitelli, A. Polli, C. I. Ferrari, I. Ismail, and M. F. Scanlon, “A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea,” The New England Journal of Medicine, vol. 331, no. 14, pp. 904–909, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Verhelst, R. Abs, D. Maiter et al., “Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 7, pp. 2518–2522, 1999. View at Google Scholar · View at Scopus
  11. T. Sabuncu, E. Arikan, E. Tasan, and H. Hatemi, “Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients,” Internal Medicine, vol. 40, no. 9, pp. 857–861, 2001. View at Google Scholar · View at Scopus
  12. L. Sandret, P. Maison, and P. Chanson, “Place of cabergoline in acromegaly: a meta-analysis,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 5, pp. 1327–1335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Garibi, I. Pomposo, G. Villar, and S. Gaztambide, “Giant pituitary adenomas: clinical characteristics and surgical results,” British Journal of Neurosurgery, vol. 16, no. 2, pp. 133–139, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Melmed, “Medical progress: acromegaly,” The New England Journal of Medicine, vol. 322, no. 14, pp. 966–977, 1990. View at Google Scholar · View at Scopus
  15. J. S. Bevan, J. Webster, C. W. Burke, and M. F. Scanlon, “Dopamine agonists and pituitary tumor shrinkage,” Endocrine Reviews, vol. 13, no. 2, pp. 220–240, 1992. View at Publisher · View at Google Scholar · View at Scopus